Lawsuit says the merger would solidify Novo Nordisk’s market position as a leader in the field of obesity drugs by killing off a smaller competitor.

Pfizer on Friday filed a lawsuit against Metsera and Novo Nordisk, saying Metsera breached its merger agreement obligations in declaring the Danish drugmaker's $8.5 billion bid for the U.S. obesity ...

Signed, sealed and delivered, Metsera is finally Pfizer’s. Pfizer has completed its acquisition of the obesity biotech, ...

Pfizer has won a $10 billion deal to acquire the fast-rising obesity drug developer Metsera, ending a fierce bidding war with Danish rival Novo Nordisk. Metsera accepted a sweetened offer from Pfizer ...

Pfizer has now filed a suit in federal court, following its claim in state court on Friday. It is riding Trump-era political currents in its efforts to save the deal.

Novo Nordisk’s CEO dared Pfizer to bid more if it wanted obesity drug developer Metsera so badly. So Pfizer did, with a $10 billion bid that edges out what the Danish pharmaceutical giant was willing ...

A judge denied Pfizer's (PFE) request to temporarily block Novo Nordisk's (NVO) $10 billion bid for Metsera. Metsera rose 2.5% in after-hours trading. Delaware Chancery Judge Morgan Zurn made the ...

Amid the rapidly unfolding saga revolving around Metsera, a judge has denied Pfizer’s request to block Novo Nordisk’s buyout bid for the biotech, Bloomberg reports. Delaware Chancery Judge Morgan Zurn ...

Novo Nordisk (NVO) on Saturday said it will no longer increase its buyout offer for Metsera (MTSR) after Pfizer (PFE) won a bitter bidding war for the U.S. weight-loss drug developer, reaching a deal ...

FILE - The Pfizer logo is displayed at the company's headquarters, Friday, Feb. 5, 2021, in New York. (AP Photo/Mark Lennihan, File) NEW YORK (AP) — U.S. pharmaceutical giant Pfizer signed a deal to ...

Under the deal, Pfizer will pay $86.25 per share, consisting of $65.60 in cash and a contingent value right worth up to $20.65 per share, depending on future milestones. Metsera's board unanimously ...

A judge denied Pfizer Inc.’s request to temporarily block Novo Nordisk A/S’ $10 billion bid to acquire the obesity startup Metsera Inc., saying the US pharmaceutical company’s objections to the deal ...